Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Hematological Malignancies”

766 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 766 results

Testing effectiveness (Phase 2)Ended earlyNCT00698685
What this trial is testing

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaLymphomaHodgkin's Disease+3 more
University of Arizona 14
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Early research (Phase 1)Study completedNCT02352558
What this trial is testing

BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Who this might be right for
Hematologic Malignancy
Sumitomo Pharma America, Inc. 15
Not applicableLooking for participantsNCT02760238
What this trial is testing

Myeloproliferative Neoplasms (MPNs) Patient Registry

Who this might be right for
Primary MyelofibrosisPolycythemia VeraEssential Thrombocythemia+7 more
University Health Network, Toronto 5,000
Early research (Phase 1)Not Yet RecruitingNCT07044544
What this trial is testing

Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

Who this might be right for
Myeloid MalignancyHematologic MalignancyAcute Myeloid Leukemia+1 more
University of Alabama at Birmingham 20
Testing effectiveness (Phase 2)Study completedNCT00245037
What this trial is testing

Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
OHSU Knight Cancer Institute 147
Early research (Phase 1)Ended earlyNCT03198234
What this trial is testing

Use of T-allo10 in Hematopoietic Stem Cell Transplantation (HSCT) for Blood Disorders

Who this might be right for
AML - Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Mixed Phenotype Acute Leukemia+3 more
Roncarolo, Maria Grazia, MD 5
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT05768035
What this trial is testing

Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide

Who this might be right for
Hematological Malignancies
Smart Immune SAS 40
Early research (Phase 1)Looking for participantsNCT07321626
What this trial is testing

Romiplostim N01 for Platelet Recovery After Haploidentical HSCT

Who this might be right for
Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)Delayed Platelet Engraftment+1 more
First Affiliated Hospital of Zhejiang University 130
Early research (Phase 1)Study completedNCT01684150
What this trial is testing

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+1 more
Epizyme, Inc. 51
Not applicableUnknownNCT02885623
What this trial is testing

Role of CX3CR1-expressing Cells in Hematologic Malignancy

Who this might be right for
CX3CR1 ProteinDiffuse Large B Cell LymphomaMultiple Myeloma
Saint Vincent's Hospital, Korea 50
Testing effectiveness (Phase 2)Study completedNCT00674479
What this trial is testing

INCB018424 in Patients With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome+1 more
M.D. Anderson Cancer Center 51
Early research (Phase 1)Study completedNCT05665530
What this trial is testing

PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Mantle Cell Lymphoma (MCL)+9 more
Prelude Therapeutics 86
Not applicableStudy completedNCT00186342
What this trial is testing

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

Who this might be right for
Acute DiseaseMyelodysplastic SyndromesLeukemia, Myeloid, Chronic+4 more
Stanford University 120
Not applicableNot Yet RecruitingNCT07112287
What this trial is testing

Germline Testing for Predisposition to Myeloid Malignancies

Who this might be right for
Myeloid MalignancyGenetic Predisposition to DiseaseMyeloid Hematological Malignancies
Christopher Reilly 200
Testing effectiveness (Phase 2)Study completedNCT00003406
What this trial is testing

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Cancer Treatment Centers of America 30
Not applicableLooking for participantsNCT05735704
What this trial is testing

Early Detection and Screening of Hematological Malignancies - SANGUINE

Who this might be right for
Hematologic Malignancy
JaxBio Ltd 3,000
Testing effectiveness (Phase 2)Study completedNCT01200485
What this trial is testing

Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 55
Load More Results